A systematic review of clinical effectiveness of wound edge protector devices in reducing surgical site infections in patients undergoing abdominal surgery

2017 ◽  
Vol 69 (1) ◽  
pp. 21-28 ◽  
Author(s):  
Muhammad Shafique Sajid ◽  
M. A. Rathore ◽  
P. Sains ◽  
K. K. Singh
PLoS ONE ◽  
2015 ◽  
Vol 10 (3) ◽  
pp. e0121187 ◽  
Author(s):  
André L. Mihaljevic ◽  
Tara C. Müller ◽  
Victoria Kehl ◽  
Helmut Friess ◽  
Jörg Kleeff

2015 ◽  
Vol 400 (2) ◽  
pp. 167-181 ◽  
Author(s):  
Tara C. Mueller ◽  
Martin Loos ◽  
Bernhard Haller ◽  
André L. Mihaljevic ◽  
Ulrich Nitsche ◽  
...  

2016 ◽  
Vol 17 (2) ◽  
pp. 138-151 ◽  
Author(s):  
Khalid Ahmed ◽  
Khalid Bashar ◽  
Tara T.M. Connelly ◽  
Tom Fahey ◽  
Stewart R. Walsh

2015 ◽  
Vol 36 (2) ◽  
pp. 169-179 ◽  
Author(s):  
Anucha Apisarnthanarak ◽  
Nalini Singh ◽  
Aila Nica Bandong ◽  
Gilbert Madriaga

OBJECTIVETo analyze available evidence on the effectiveness of triclosan-coated sutures (TCSs) in reducing the risk of surgical site infection (SSI).DESIGNSystematic review and meta-analysis.METHODSA systematic search of both randomized (RCTs) and nonrandomized (non-RCT) studies was performed on PubMed Medline, OVID, EMBASE, and SCOPUS, without restrictions in language and publication type. Random-effects models were utilized and pooled estimates were reported as the relative risk (RR) ratio with 95% confidence interval (CI). Tests for heterogeneity as well as meta-regression, subgroup, and sensitivity analyses were performed.RESULTSA total of 29 studies (22 RCTs, 7 non-RCTs) were included in the meta-analysis. The overall RR of acquiring an SSI was 0.65 (95% CI: 0.55–0.77; I2=42.4%, P=.01) in favor of TCS use. The pooled RR was particularly lower for the abdominal surgery group (RR: 0.56; 95% CI: 0.41–0.77) and was robust to sensitivity analysis. Meta-regression analysis revealed that study design, in part, may explain heterogeneity (P=.03). The pooled RR subgroup meta-analyses for randomized controlled trials (RCTs) and non-RCTs were 0.74 (95% CI: 0.61–0.89) and 0.53 (95% CI: 0.42–0.66), respectively, both of which favored the use of TCSs.CONCLUSIONThe random-effects meta-analysis based on RCTs suggests that TCSs reduced the risk of SSI by 26% among patients undergoing surgery. This effect was particularly evident among those who underwent abdominal surgery.Infect Control Hosp Epidemiol 2015;36(2): 1–11


Sign in / Sign up

Export Citation Format

Share Document